AstraZeneca plays up China, downplays patent loss in latest earnings: CFO - Yahoo Finance
finance.yahoo.comSubmitted by yahooentertainment6306 in business
AstraZeneca (AZN) reported strong earnings Friday, including $22 billion, or 4% revenue growth, in the first half of the year, and kept its 2023 forecast...